PMID- 34235314 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210709 IS - 2470-1343 (Electronic) IS - 2470-1343 (Linking) VI - 6 IP - 25 DP - 2021 Jun 29 TI - Adeno-associated Virus Virus-like Particle Characterization via Orthogonal Methods: Nanoelectrospray Differential Mobility Analysis, Asymmetric Flow Field-Flow Fractionation, and Atomic Force Microscopy. PG - 16428-16437 LID - 10.1021/acsomega.1c01443 [doi] AB - Adeno-associated virus (AAV)-based virus-like particles (VLPs) are thriving vectors of choice in the biopharmaceutical field of gene therapy. Here, a method to investigate purified AAV serotype 8 (AAV8) batches via a nanoelectrospray gas-phase mobility molecular analyzer (nES GEMMA), also known as an nES differential mobility analyzer, is presented. Indeed, due to AAV's double-digit nanometer scale, nES GEMMA is an excellently suited technique to determine the surface-dry particle size termed electrophoretic mobility diameter of such VLPs in their native state at atmospheric pressure and with particle-number-based detection. Moreover, asymmetric flow field-flow fractionation (AF4, also known as AFFFF) and atomic force microscopy (AFM) techniques were employed as orthogonal techniques for VLP characterization. In addition, AF4 was implemented to size-separate as well as to enrich and collect fractions of AAV8 VLPs after inducing analyte aggregation in the liquid phase. Bionanoparticle aggregation was achieved by a combination of heat and shear stress. These fractions were later analyzed with nES GEMMA (in the gas phase) and AFM (on a solid surface). Both techniques confirm the presence of dimers, trimers, and putative VLP oligomers. Last, AFM reveals even larger AAV8 VLP aggregates, which were not detectable by nES GEMMA because their heterogeneity combined with low abundance was below the limit of detection of the instrument. Hence, the combination of the employed orthogonal sizing methods with the separation technique AF4 allow a comprehensive characterization of AAV8 VLPs applied as vectors. CI - (c) 2021 The Authors. Published by American Chemical Society. FAU - Zoratto, Samuele AU - Zoratto S AD - Institute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria. FAU - Weiss, Victor U AU - Weiss VU AUID- ORCID: 0000-0002-0056-6819 AD - Institute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria. FAU - Friedbacher, Gernot AU - Friedbacher G AD - Institute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria. FAU - Buengener, Carsten AU - Buengener C AD - Pharmaceutical Sciences, Baxalta Innovations (part of Takeda), Vienna A-1221, Austria. FAU - Pletzenauer, Robert AU - Pletzenauer R AD - Pharmaceutical Sciences, Baxalta Innovations (part of Takeda), Vienna A-1221, Austria. FAU - Foettinger-Vacha, Alexandra AU - Foettinger-Vacha A AD - Institute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria. FAU - Graninger, Michael AU - Graninger M AD - Pharmaceutical Sciences, Baxalta Innovations (part of Takeda), Vienna A-1221, Austria. FAU - Allmaier, Guenter AU - Allmaier G AUID- ORCID: 0000-0002-1438-9462 AD - Institute of Chemical Technologies and Analytics, TU Wien (Vienna University of Technology), Vienna A-1060, Austria. LA - eng PT - Journal Article DEP - 20210615 PL - United States TA - ACS Omega JT - ACS omega JID - 101691658 PMC - PMC8246466 COIS- The authors declare the following competing financial interest(s): Carsten Buengener, Robert Pletzenauer, Alexandra Foettinger-Vacha and Michael Graninger are or were employees of Baxalta Innovations (part of Takeda). EDAT- 2021/07/09 06:00 MHDA- 2021/07/09 06:01 PMCR- 2021/06/15 CRDT- 2021/07/08 06:46 PHST- 2021/03/17 00:00 [received] PHST- 2021/05/27 00:00 [accepted] PHST- 2021/07/08 06:46 [entrez] PHST- 2021/07/09 06:00 [pubmed] PHST- 2021/07/09 06:01 [medline] PHST- 2021/06/15 00:00 [pmc-release] AID - 10.1021/acsomega.1c01443 [doi] PST - epublish SO - ACS Omega. 2021 Jun 15;6(25):16428-16437. doi: 10.1021/acsomega.1c01443. eCollection 2021 Jun 29.